UCLA DA 225.40: Execution of Documents Related to Material Transfer Agreements
Date:
June 04, 2012
PDF of DelegationPrint
From: Associate Vice Chancellor for Research Brendan Rauw
To: Director, Licensing Emily Loughran
Director, Industry Sponsored Research and Material Transfer Brian Roe
Director, Strategic Initiatives in OIP & ISR Lillian L. Smith
Industry Contract Officers
MTA Analysts
Senior Administrative Analyst in Pharmacology
References:
  1. UC DA 2569 (To Solicit and Accept or Execute Certain Extramural Grants and Contracts) to Chancellors, dated April 19, 2012;
  2. University of California Contract and Grant Manual;
  3. National Institutes of Health (NIH) – General Information on Uniform Biological Material Transfer Agreements (UBMTA);
  4. University of California Patent Policy
Supersedes: UCLA DA 225.37 (Execution of Documents Related to Material Transfer Agreements) to Directors Loughran and Smith, et al., dated 4/4/2011.
Effective as of the date, above, I hereby delegate to you, in your respective areas of responsibility, the authority to execute Material Transfer Agreements (MTA) and Uniform Biological Material Transfer Agreements (UBMTA) in accordance with the UC policies, and as specified in the following Delegated Authority Matrix:
 
To Execute Outgoing & Incoming MTAs & UBMTAs & Propose Appropriate Exceptions to UC Policies:
To Execute Outgoing and Incoming UBMTAs:
To Execute Standard Outgoing and Incoming MTAs from Non-Profit Organizations:
To Execute Standard Outgoing and Incoming MTAs from For-Profit Organizations:
Director, Licensing
X
X
 		X
X
Director, Industry Sponsored Research*
X
X
X
X
Director Strategic Initiatives in OIP & ISR
X
X
X
X
Industry Contract Officer(s)
X
X
X
n/a
MTA Analyst(s)
n/a
X
X
n/a
Senior Administrative Analyst in Pharmacology
n/a
n/a
X
n/a
* May also approve proposed exceptions to UC Policies

For purposes of this delegation, an MTA is a written agreement entered into by a provider and a recipient of research material. The intent of the MTA is to protect the intellectual property rights and other rights of the parties while permitting research with the material to proceed. The most common subjects of material transfer agreements are biological materials and chemical compounds. However, MTAs may also be used to transfer other types of materials including, but not limited to, databases and software. The provider of the materials does not provide research funding for the project. The materials are not to be used in humans.

There are three forms of material transfer that commonly arise at academic institutions, each calling for different terms and conditions. They are: material transfer between academic institutions; material transfer from industry to UCLA; and material transfer from UCLA to industry. To encourage the process of sharing research tools between scientists, the NIH and the Association of University Technology Managers (AUTM) have developed standard language to simplify material transfers between academic institutions. The Uniform Biological Material Transfer Agreement (UBMTA) shall generally be used for such material transfers whenever possible.

This delegation is being reissued due to the reissuance of the parent OP delegation and to organization changes. Also, a distinction has been made between for-profit and non-profit organizations. This authority may not be further redelegated

cc: Chancellor
Executive Vice Chancellor & Provost
Vice Chancellor for Research
Assistant Vice Chancellor for Research
Manager, Administrative Policies & Delegations